Lipocine Reports Topline Results From Phase 2 Proof-Of-Concept Study of LPCN 1148 in Liver Cirrhosis
We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.